Assessing the safety of stem cell therapeutics.

Unprecedented developments in stem cell research herald a new era of hope and expectation for novel therapies. However, they also present a major challenge for regulators since safety assessment criteria, designed for conventional agents, are largely inappropriate for cell-based therapies. This article aims to set out the safety issues pertaining to novel stem cell-derived treatments, to identify knowledge gaps that require further research, and to suggest a roadmap for developing safety assessment criteria. It is essential that regulators, pharmaceutical providers, and safety scientists work together to frame new safety guidelines, based on "acceptable risk," so that patients are adequately protected but the safety "bar" is not set so high that exciting new treatments are lost.

[1]  Jehyuk Lee,et al.  Generation of functional human hepatic endoderm from human induced pluripotent stem cells , 2009, Hepatology.

[2]  Yang D. Teng,et al.  Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells , 2007, Proceedings of the National Academy of Sciences.

[3]  N. Benvenisty,et al.  The tumorigenicity of diploid and aneuploid human pluripotent stem cells , 2009, Cell cycle.

[4]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[5]  Donald W. Fink.  FDA Regulation of Stem Cell–Based Products , 2009, Science.

[6]  N. Benvenisty,et al.  Clonal Analysis of Human Embryonic Stem Cell Differentiation into Teratomas , 2007, Stem cells.

[7]  S. Sedrakyan,et al.  Stem Cell and Regenerative Science Applications in the Development of Bioengineering of Renal Tissue , 2008, Pediatric Research.

[8]  Julie V. Harness,et al.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.

[9]  Svetlana V. Ukraintseva,et al.  Cancer in rodents: does it tell us about cancer in humans? , 2005, Nature Reviews Cancer.

[10]  M. Schuldiner,et al.  Factors controlling human embryonic stem cell differentiation. , 2003, Methods in enzymology.

[11]  J. Itskovitz‐Eldor,et al.  Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[13]  Elizabeth E. Hoskins,et al.  Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro , 2010, Nature.

[14]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[15]  Riitta Lahesmaa,et al.  Copy number variation and selection during reprogramming to pluripotency , 2011, Nature.

[16]  N. Benvenisty,et al.  The immunogenicity of human embryonic stem-derived cells. , 2004, Trends in biotechnology.

[17]  O. Yanuka,et al.  Differentiation and isolation of hepatic-like cells from human embryonic stem cells. , 2004, Differentiation; research in biological diversity.

[18]  Pengyuan Zhang,et al.  A Fibrin Patch‐Based Enhanced Delivery of Human Embryonic Stem Cell‐Derived Vascular Cell Transplantation in a Porcine Model of Postinfarction Left Ventricular Remodeling , 2011, Stem cells.

[19]  S. Mayor.  First patient enters trial to test safety of stem cells in spinal injury , 2010, BMJ : British Medical Journal.

[20]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[21]  S. Sadiq,et al.  Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice. , 2011, Stem cells and development.

[22]  Michel Sadelain,et al.  Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells , 2011, Nature Biotechnology.

[23]  J. Lebkowski,et al.  Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells , 2007, Journal of Neuroimmunology.

[24]  Yoav Mayshar,et al.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.

[25]  S. Cheong,et al.  Induced pluripotent stem cells in research and therapy. , 2012, The Malaysian journal of pathology.

[26]  A. Hamburger.  The human tumor clonogenic assay as a model system in cell biology. , 1987, International journal of cell cloning.

[27]  A. Caplan,et al.  The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion , 2001, Cells Tissues Organs.

[28]  D. G. Halme,et al.  FDA regulation of stem-cell-based therapies. , 2006, The New England journal of medicine.

[29]  Robert Passier,et al.  Increased Cardiomyocyte Differentiation from Human Embryonic Stem Cells in Serum‐Free Cultures , 2005, Stem cells.

[30]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[31]  A. Terzic,et al.  Stem Cells and Cloning: Advances and Applications , 2009 .

[32]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[33]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[34]  Tomoaki Tanaka,et al.  Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions , 2011, Journal of cellular and molecular medicine.

[35]  H. Bernstein,et al.  Cardiac regeneration using human embryonic stem cells: producing cells for future therapy. , 2010, Regenerative medicine.

[36]  M. Kubista,et al.  Monitoring Differentiation of Human Embryonic Stem Cells Using Real‐Time PCR , 2005, Stem cells.

[37]  H. Okano,et al.  Benefits of utilizing gene-modified iPSCs for clinical applications. , 2010, Cell stem cell.

[38]  Joseph C. Wu,et al.  Embryonic stem cell biology: insights from molecular imaging. , 2010, Methods in molecular biology.

[39]  R. Pedersen,et al.  Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development , 2010, Hepatology.

[40]  N. Benvenisty,et al.  The tumorigenicity of human embryonic and induced pluripotent stem cells , 2011, Nature Reviews Cancer.

[41]  C. Svendsen,et al.  Chromosome 7 and 19 Trisomy in Cultured Human Neural Progenitor Cells , 2009, PloS one.

[42]  Giulio Cossu,et al.  New ISSCR guidelines underscore major principles for responsible translational stem cell research. , 2008, Cell stem cell.

[43]  Catherine Payne,et al.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling , 2008, Proceedings of the National Academy of Sciences.

[44]  A. Chakravarti,et al.  Genomic alterations in cultured human embryonic stem cells , 2005, Nature Genetics.

[45]  L. Vallier.  Serum-free and feeder-free culture conditions for human embryonic stem cells. , 2011, Methods in molecular biology.

[46]  A. Mackay-Sim,et al.  Induced pluripotent stem cells: a new technology to study human diseases. , 2011, The international journal of biochemistry & cell biology.

[47]  P. Andrews,et al.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo , 2007, Nature Biotechnology.

[48]  J. Kere,et al.  A Teratocarcinoma-Like Human Embryonic Stem Cell (hESC) Line and Four hESC Lines Reveal Potentially Oncogenic Genomic Changes , 2010, PloS one.

[49]  P. Fairchild.  The challenge of immunogenicity in the quest for induced pluripotency , 2010, Nature Reviews Immunology.

[50]  S. V. Anisimov,et al.  Risks and Mechanisms of Oncological Disease Following Stem Cell Transplantation , 2010, Stem Cell Reviews and Reports.

[51]  A. Caplan,et al.  Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.

[52]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[53]  Dusko Ilic,et al.  Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells , 2010, Journal of The Royal Society Interface.

[54]  Ying Meng,et al.  Differentiation and Enrichment of Hepatocyte‐Like Cells from Human Embryonic Stem Cells In Vitro and In Vivo , 2007, Stem cells.

[55]  M. Grompe,et al.  Generation and Regeneration of Cells of the Liver and Pancreas , 2008, Science.

[56]  Gideon Rechavi,et al.  Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient , 2009, PLoS medicine.

[57]  N. Benvenisty,et al.  The tumorigenicity of human embryonic stem cells. , 2008, Advances in cancer research.

[58]  Concepcion R. Nierras,et al.  The promise of human induced pluripotent stem cells for research and therapy , 2008, Nature Reviews Molecular Cell Biology.

[59]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[60]  Shinya Yamanaka,et al.  Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.

[61]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[62]  Rutger-Jan Swijnenburg,et al.  Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts , 2008, Proceedings of the National Academy of Sciences.

[63]  K. Athanasiou,et al.  Tissue Engineering with Chondrogenically Differentiated Human Embryonic Stem Cells , 2007, Stem cells.

[64]  David Tosh,et al.  A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3 , 2011, Development.

[65]  K. Ohlsen,et al.  Visualization of Abscess Formation in a Murine Thigh Infection Model of Staphylococcus aureus by 19F-Magnetic Resonance Imaging (MRI) , 2011, PloS one.

[66]  K. A. Krishna,et al.  Stem cell-based therapy for the treatment of Type 1 diabetes mellitus. , 2007, Regenerative medicine.

[67]  J. Falkenburg,et al.  Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. , 2002, Experimental hematology.

[68]  Marius Wernig,et al.  In vitro differentiation of transplantable neural precursors from human embryonic stem cells , 2001, Nature Biotechnology.

[69]  N. Hanley,et al.  Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. , 2010, Stem cell research.